Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

Nature Medicine

Volumn 2, Issue 8, 1996, Pages 876-882

  Hanenberg, Helmut ^a   Xiao, Xiang Li ^a   Dilloo, Dagmar ^b   Hashino, Kimikazu ^c   Kato, Ikunoshin ^c   Williams, David A ^a,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c TAKARA SHUZO CO LTD   (Japan)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; RECOMBINANT PROTEIN;

ANIMAL CELL; CELL ADHESION; CELL STRAIN 3T3; CELL STRAIN HL 60; CELL STRAIN K 562; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; REVIEW; STEM CELL TRANSPLANTATION; TARGET CELL; VIRUS PARTICLE;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; FETAL BLOOD; FIBRONECTINS; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MAMMALS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RETROVIRIDAE; TRANSFORMATION, GENETIC;

EID: 16044366110     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0896-876     Document Type: Review

References (39)

1. Morrison, S.J., Uchida, N. & Weissman, I.L. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11, 35-71 (1995).
2. Mulligan, R.C. The basic science of gene therapy. Science 260, 926-932 (1993).
3. Williams, D.A., Lemischka, I.R., Nathan, D.G. & Mulligan, R.C. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse. Nature 310, 476-480 (1984).
4. Dick, J.E., Magli, M.C., Huszar, D., Phillips, R.A. & Bernstein, A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell 42, 71-79 (1985).
5. Keller, G., Paige, C., Gilboa, E. & Wagner, E.F. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent hematopoietic precursors. Nature 318, 149-154 (1985).
6. Lemischka, I.R., Raulet, D.H. & Mulligan, R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45, 917-927 (1986).
7. Bordignon, C. et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science 270, 470-475 (1995).
8. Brenner, M.K. et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134-1137 (1993).
9. Deisseroth, A.B. et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83, 3068-3076 (1994).
10. Dunbar, C.E. et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048-3057 (1995).
11. Blaese, R.M. et al. T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480 (1995).
12. Kohn, D.B. et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017-1023 (1995).
13. Bodine, D.M., McDonagh, K.T., Seidel, N.E. & Nienhuis, A.W. Survival and retrovirus infection of murine hematopoietic stem cells in vitro: Effects of 5-FU and method of infection. Exp. Hematol. 19, 206-212 (1991).]
14. Yoder, M.C. & Williams, D.A. Matrix molecule interactions with hematopoietic stem cells. Exp. Hematol. 23, 961-967 (1995).
15. Williams, D.A., Rios, M., Stephens, C. & Patel, V.P. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352, 438-441 (1991).
16. Verfaillie, C.M., McCarthy, J.B. & McGlave, P.B. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J. Exp. Med. 174, 693-703 (1991).
17. Verfaillic, CM., Benis, A., Iida, J., McGlave, P.B. & McCarthy, J.B. Adhesion of committed human hematopoietic progenitors to synthetic peptides from the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin alpha 4 beta 1 and the CD44 adhesion receptor. Blood 84, 1802-1811 (1994).
18. Ruoslahti, E. Fibronectin and its receptors. Annu. Rev. Biochem. 57, 375-413 (1988).
19. Hynes, R.O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25 (1992).
20. Moritz, T., Patel, V.P. & Williams, D.A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J. Clin. Invest. 93, 1451-1457 (1994).
21. Kimizuka, F. et al. Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. J. Biochem. 110, 284-291 (1991).
22. Clapp, D.W. et al. Myeloproliferative sarcoma virus directed expression of betagalactosidase following retroviral transduction of murine hematopoietic cells. Exp. Hematol. 23, 630-638 (1995).
23. Bradley, T.R. & Hodgson, G.S. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 54, 1446-1450 (1979).
24. Williams, D.A., Orkin, S.H. & Mulligan, R.C. Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc. Katl. Acml. Sci. USA 83, 2566-2570 (1986).
25. Moritz, T., Keller, D.C. & Williams, D.A. Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J. Exp. Med. 178, 529-536 (1993).
26. Dalton, S.L., Marcantonio, E.E. & Assoian, R.K. Cell attachment controls fibronectin and alpha 5 beta 1 integrin levels in fibroblasts. Implications for anchorage-dependent and -independent growth. J. Biol. Chem. 267, 8186-8191 (1992).
27. Patel, V.P. & Lodish, H.F. The fibronectin receptor on mammalian erythroid precursor cells: Characterization and developmental regulation. J. Cell Biol. 102, 449-156 (1986).
28. Tsai, S. et al. Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin. Blood 69, 1587-1594 (1987).
29. Orkin, S.H. & Motulsky, A.G. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. December 7, 1995. www.nih.gov/news/panelrep.html (1995).
30. Moritz, T. et al. Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood, in press (1996).
31. Rider, C.C. et al. Anti-HIV-1 activity of chemically modified heparins: Correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry 33, 6974-6980 (1994).
32. Dhawan, S. et al. Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-Infected lymphocytes. Virology 197, 778-781 (1993).
33. Bork, P. & Doolittle, R.F. Fibronectin type III modules in the receptor phosphatase CD45 and tapeworm antigens. Protein Sci. 2, 1185-1187 (1993).
34. Peles, E. et al. The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 82, 251-260 (1995).
35. Markowitz, D., Goff, S. & Bank, A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124 (1988).
36. Lim, B., Williams, D.A. & Orkin, S.H. Retrovirus-mediated gene transfer of human adenosine deaminase: Expression of functional enzyme in murine hematopoietic stem cells in vivo. Mol. Cell. Biol. 7, 3459-3465 (1987).
37. Markowitz, D., Goff, S. & Bank, A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406 (1988).
38. Johnson, D. et al. Expression and structure of the human NGF receptor. Cell 47, 545-554 (1986).
39. Miller, A.D. Retrovirus packaging cells. Hum. Gene Ther. 1, 5-14 (1990).